Skip to content

Mapping Snakebite Risk in Kenya and Eswatini

Mapping Snakebite Risk in Kenya and Eswatini: Using Primary Data Collection and Geostatistical Techniques to Develop an Approach to Remote Risk Estimation for Snakebite

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06124872
Enrollment
70000
Registered
2023-11-09
Start date
2023-06-01
Completion date
2024-12-31
Last updated
2023-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epidemiology, Snakebite

Brief summary

The goal of this observational study is to learn about how snakebite risk varies in different environments in Kenya and understand how this information can be used to support decision makers. The main questions it aims to answer are: 1. To what extent can information on snakebite cases and data on geographic, climatic and sociodemographic factors be used to predict geographical variation in snakebite risk in Kenya and Eswatini? 2. What is the most effective means of presenting outputs from spatial analysis of snakebite risk to ensure its effective use in research and healthcare decision making? Participants in the community survey will be asked survey questions about the history of snakebite in their household. Participants in the key informant interviews will be interviewed to understand how data on snakebite risk can be best presented to support their work.

Detailed description

This study aims to understand whether spatial analysis methods can support the assessment and prediction of geographical variation in snakebite risk. The investigators will analyse data collected from community and health facility surveys conducted in geographically, ecologically and demographically diverse areas of Kenya and Eswatini. Data sources will comprise existing snakebite incidence data from both countries and prospective data collected through adding snakebite questions to planned health/demographic survey platforms where feasible and conducting a small number of stand-alone cluster-sampled surveys to complement this. Selected households will be invited to complete short questionnaires covering sociodemographic details and snakebite history. Survey data will be compared with health facility data collected in the same locations to assess the value and relative bias of different data sources to snakebite risk assessment. Data will be analysed using geostatistical techniques, and predicted risk will be mapped within and beyond sampled locations where appropriate. Our findings will build knowledge on spatial determinants of snakebite within these countries and support development of a risk mapping methodology for snakebite. Identification of high-risk locations will also support advocacy for resources and guide treatment and prevention activities. Interviews will also be conducted with key stakeholders in healthcare and research fields in Kenya to help us understand the healthcare decision-making process and how outputs from spatial analysis of snakebite data can be best presented to support this. Interview results will aid development of recommendations for the optimal presentation of snakebite data to support programmatic decision making.

Interventions

Household screening questionnaire Snakebite details questionnaire where a history of snakebite is reported

OTHERKey informant interview

Semi-structured interview with selected key informants

Sponsors

Kenya Medical Research Institute
CollaboratorOTHER
Institute of Primate Research
CollaboratorOTHER_GOV
Liverpool School of Tropical Medicine
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

Household Screening Questionnaire: * All heads of household from randomly selected households. * To account for all household members Snakebite Details Questionnaire: • All household members with a history of snakebite. If the household member is deceased, a responsible adult from the household will be asked to complete the questionnaire. Key informant interviews: * Key informants identified through a stakeholder mapping exercise as having power and/or influence in healthcare decision making or research with relation to Neglected Tropical Diseases/snakebite. * Willing and motivated to be interviewed

Exclusion criteria

Household Screening Questionnaire: * Households where the household head/a responsible adult is not present at first visit or revisit. * Household where the household head/responsible adult is unable or unwilling to give consent Snakebite Details Questionnaire: • The household member is unable/unwilling to give consent and (in the case of the former) there is no responsible adult available/willing to complete the questionnaire on their behalf Key informant interviews: * A participant whose role and organisation has already been represented in the key informant interviews * Participant declines to be interviewed

Design outcomes

Primary

MeasureTime frameDescription
Geostatistical model of snakebite risk in Kenya and EswatiniThrough study completion, estimated end of 2024A geostatistical model of snakebite risk, detailing the statistical association between selected covariates and snakebite risk, based on analysis of data on snakebite incidence collected from contrasting locations in Kenya and Eswatini.
An assessment of the accuracy of snakebite incidence data reported from routine surveillance systems relative to community survey estimatesThrough study completion, estimated end of 2024An assessment of the accuracy of routine surveillance data sources in relation to community survey incidence estimates (the gold standard measure) in each study location.
RecommendationsThrough study completion, estimated end of 2024A thematic analysis of key informant interviews on the potential role of and key features needed in snakebite risk maps in order for them to provide utility in healthcare decision making and a set of recommendations to guide presentation of spatial outputs on snakebite risk.

Countries

Kenya

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026